BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32488819)

  • 1. Filtrated Adipose Tissue-Derived Mesenchymal Stem Cell Lysate Ameliorates Experimental Acute Colitis in Mice.
    Nishikawa T; Maeda K; Nakamura M; Yamamura T; Sawada T; Mizutani Y; Ito T; Ishikawa T; Furukawa K; Ohno E; Miyahara R; Kawashima H; Honda T; Ishigami M; Yamamoto T; Matsumoto S; Hotta Y; Fujishiro M
    Dig Dis Sci; 2021 Apr; 66(4):1034-1044. PubMed ID: 32488819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells.
    Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S
    Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
    Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
    Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Efficacy of Tonsil-derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-induced Acute Murine Colitis Model.
    Song EM; Jung SA; Lee KE; Jang JY; Lee KH; Tae CH; Moon CM; Joo YH; Kim SE; Jung HK; Shim KN
    Korean J Gastroenterol; 2017 Feb; 69(2):119-128. PubMed ID: 28239080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
    Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
    Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide Dismutase 3-Transduced Mesenchymal Stem Cells Preserve Epithelial Tight Junction Barrier in Murine Colitis and Attenuate Inflammatory Damage in Epithelial Organoids.
    Tak LJ; Kim HY; Ham WK; Agrahari G; Seo Y; Yang JW; An EJ; Bang CH; Lee MJ; Kim HS; Kim TY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E
    An JH; Song WJ; Li Q; Kim SM; Yang JI; Ryu MO; Nam AR; Bhang DH; Jung YC; Youn HY
    BMC Vet Res; 2018 Nov; 14(1):354. PubMed ID: 30453939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis.
    Heidari M; Pouya S; Baghaei K; Aghdaei HA; Namaki S; Zali MR; Hashemi SM
    J Cell Physiol; 2018 Nov; 233(11):8754-8766. PubMed ID: 29797577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice.
    Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY
    Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell-derived membrane particles: A novel cell-free therapy for inflammatory bowel diseases.
    Serafini MA; Sirena DH; da Silveira ABT; Franco-da-Silva M; Aubin MR; Garcez TNA; Araújo A; Dos Santos Pereira F; Hoogduijn MJ; da Costa Gonçalves F; Paz AH
    Int Immunopharmacol; 2023 May; 118():110076. PubMed ID: 37030123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.
    He XW; He XS; Lian L; Wu XJ; Lan P
    Dig Dis Sci; 2012 Dec; 57(12):3136-44. PubMed ID: 22752635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.
    Alves VBF; de Sousa BC; Fonseca MTC; Ogata H; Caliári-Oliveira C; Yaochite JNU; Rodrigues Júnior V; Chica JEL; da Silva JS; Malmegrim KCR; Pernomian L; Cardoso CR
    Clin Exp Immunol; 2019 May; 196(2):139-154. PubMed ID: 30663040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse model.
    Yu Y; Zhao T; Yang D
    Exp Anim; 2017 May; 66(2):167-176. PubMed ID: 28100889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
    Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
    Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.
    Niu GC; Liu L; Zheng L; Zhang H; Shih DQ; Zhang X
    BMC Gastroenterol; 2018 Aug; 18(1):127. PubMed ID: 30103680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.